Drug Monitoring Program Records Significant Drop in Painkiller Prescriptions

OxycodoneIn the past year, the number of narcotic painkillers prescribed in New Hampshire decreased by more than 13 percent, while cases of suspected “doctor shopping” by patients dropped by nearly two-thirds.

The new data, presented to Gov. Maggie Hassan and legislative leaders earlier this month, suggest that two years after it was launched, the state’s Prescription Drug Monitoring Program is working as designed.

Michelle Ricco Jonas, the PDMP’s program manager, said the numbers show the system has changed how doctors and nurses prescribe opioids, as well as how patients use them.

Painkiller Rx_1

Prescribed doses of opioids have decreased significantly in the past 18 months.
CREDIT SARA PLOURDE

“This is showing us that the number of people seeing multiple providers and getting prescriptions filled at multiple pharmacies is decreasing,” she said. “This is something we want to see and hope to see it further decrease with the increased utility of the program.”

New Hampshire was the 49th state to authorize a program to monitor prescriptions for drugs that carry a risk of abuse. Schedule II drugs – especially opioid pain medications such as oxycodone and morphine – are the most frequently abused. Experts say years of indiscriminate prescribing of these drugs is directly linked to the state’s heroin crisis.

The PDMP went online in September 2014. In its first full year, at least 50.5 million doses of opioid pain relievers were dispensed.

That estimate is on the low end – for much of that period, the information was retained for just three months. A recent change in the law required it be kept for three years, allowing for a fuller picture of the program’s impact.

County Controlled Rx

Nearly a half-million people – about 34 percent of NH’s population – were prescribed controlled substances in FY 2016.
CREDIT SARA PLOURDE

From October through December 2015 – the first quarter of FY 2016 – some 12.4 million pain killers were dispensed. In the fourth quarter, that dropped to just over 10.7 million doses, a 13 percent decrease.

The decline in patients whose behavior suggested “doctor shopping” – using at least five prescribers and pharmacies to obtain opioids – was even more pronounced. In 2015, the PDMP flagged an average of nine patients a month who obtained prescriptions from multiple sources; that number dropped to three patients per month in the most recent fiscal year.

Use of the program by prescribers is also increasing: doctors and nurses queried the PDMP more than 300,000 times in fiscal year 2016.

But not all the news is good. The most dangerous drugs – opioids – still account for four of every 10 controlled substance dispensed in New Hampshire. Moreover, one in three residents – almost 500,000 people – received at least one prescription for a drug with the potential for abuse.

The PDMP is only one way lawmakers are trying to get their arms around a problem that killed more than 430 people in 2015.

The strategy, which includes millions in new funding for prevention, treatment and law enforcement, will likely take time to work: New Hampshire is on track to record 500 or more drug overdose deaths this year.

— Brian Wallstin, New Hampshire Public Radio

Follow Prescription Advisory

PDMPs have many limitations in their current format, including complex access issues, timeliness, and whether the data are presented to the physician automatically or require physician effort to retrieve.

ACEP - Annals of Emergency Medicine – 525

When a clinician is prescribing a controlled substance, readily available information about the drugs that a patient is receiving from other providers can be a critically important component of the decision-making process…Increasingly, these [PDMP] programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance.

Increasingly, these programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance Prescription Drug Monitoring Programs Serve a Vital Clinical Need.

Editorial  Pain Medicine, The American Academy of Pain Medicine; 2011;12:845
Rick Bunker

Rick Bunker

Rick Bunker is a co-founder, and the CEO of Prescription Advisory Systems and Technology (P.A.S.T.). In this role, he is responsible for capital formation and corporate development.
Rick Bunker
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This